Wei Huang

Wei Huang serves as President of Henlius Biopharmaceutical Ltd. In her current role, she is responsible for overseeing commercial and clinical manufacturing operation, supply chain management, facility engineering, manufacturing science and technology and quality. Served as chairperson at Aton, a CDMO subsidiary of Henlius serving clients globally, Wei is responsible for the business development, process development and technology transfer, clinical manufacturing and quality assurance. Pior to Henlius, Wei has more than 25yr of industry experience with of increasing responsibility across process and facility engineering, manufacturing science, process development and scale up. Wei holds a M.S. in Chemical and Biochemical engineering from the University of Maryland.